Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0650 CAD | 0.00% |
|
-7.14% | -53.57% |
| 07-28 | Simply Solventless Concentrates Ltd. announced that it expects to receive CAD 1 million in funding | CI |
| 06-19 | Simply Solventless Expects to File Financial Statements by July 3 | MT |
| Market Cap | 16.17M 11.54M 10.02M 9.31M 8.58M 0 16.46M 0 0 0 0 42.39M 0 | P/E 2023 |
7.5x | P/E 2024 | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 25.27M 18.03M 15.66M 14.55M 13.42M 0 25.73M 0 0 0 0 66.24M 0 | EV / Sales 2023 |
1.44x | EV / Sales 2024 | 6.8x |
| Free-Float |
81.57% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | -7.14% | ||
| Current month | +30.00% | ||
| 1 month | +30.00% | ||
| 3 months | +44.44% | ||
| 6 months | -63.89% | ||
| Current year | -53.57% |
| 1 week | 0.06 |  | 0.06 |
| 1 month | 0.04 | | 0.07 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.4 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/2/26 | Buy | Director | 5,500 | 0.0057% | ||
| 10/2/26 | Buy | Director | 5,000 | 0.0052% | ||
| 10/2/26 | Buy | Director | 9,500 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.14% | -81.16% | -75.00% | 5.36M | |
| +0.21% | +2.24% | -7.94% | -2.63% | 13.92B | |
| +0.15% | +1.94% | -28.44% | -49.20% | 5.33B | |
| -1.12% | +6.51% | +4.48% | +7.71% | 5.21B | |
| +1.56% | -0.30% | +2.24% | -31.81% | 4.11B | |
| -0.03% | +2.05% | +0.82% | -3.91% | 3.79B | |
| -0.33% | -0.67% | -2.58% | -3.17% | 3.67B | |
| +1.51% | +1.07% | -2.72% | +12.33% | 3.51B | |
| +0.90% | -0.25% | -14.25% | -23.38% | 2.44B | |
| -2.04% | +1.72% | -1.20% | +46.59% | 1.96B | |
| Average | +0.08% | +2.80% | -13.08% | -12.25% | 4.39B | |
| Weighted average by Cap. | +0.15% | +2.69% | -6.44% | -7.71% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 6.19M 4.42M 3.84M 3.56M 3.29M 0 6.3M 0 0 0 0 16.23M 0 | 13.68M 9.76M 8.48M 7.87M 7.26M 0 13.93M 0 0 0 0 35.86M 0 |
| Net income | 1.04M 742K 645K 599K 552K 0 1.06M 0 0 0 0 2.73M 0 | -5.19M -3.71M -3.22M -2.99M -2.76M -0 -5.29M -0 -0 -0 -0 -13.62M -0 |
| Net Debt | 1.63M 1.16M 1.01M 938K 865K 0 1.66M 0 0 0 0 4.27M 0 | 9.1M 6.49M 5.64M 5.24M 4.83M 0 9.26M 0 0 0 0 23.85M 0 |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | CA$0.0650 | 0.00% | 30,006 |
| 29/07/26 | CA$0.0650 | 0.00% | 123,500 |
| 28/07/26 | CA$0.0650 | 0.00% | 110,100 |
| 27/07/26 | CA$0.0650 | +8.33% | 122,225 |
| 24/07/26 | CA$0.0600 | -14.29% | 8,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
